1. Curative surgery in highly selected patients with heavily pretreated, relapsed/refractory classical Hodgkin lymphoma.
- Author
-
Papadakis, Vassilios, Efstathopoulou, Maria, Angelopoulou, Maria K., Tsourouflis, Gerassimos, Prassopoulos, Vassilios, Rondogianni, Phivi, Kourtesis, Antonios, Polychronopoulou, Sophia, Pangalis, Gerassimos A., and Vassilakopoulos, Theodoros P.
- Subjects
- *
HODGKIN'S disease , *HEMATOPOIETIC stem cell transplantation , *COMPUTED tomography , *SOLITARY pulmonary nodule - Abstract
PET/CT was not performed prior to surgery but the localized nature of the lesion was confirmed by the negative post-surgery PET/CT after the complete resection of the lesion, which had been transformed to anaplastic large cell lymphoma (ALK-negative). It is important to note that there were no other patients within the two cohorts of pediatric and adult cHL patients with 9 and 410 relapsed/refractory cases respectively, in whom a surgery-only approach was applied and failed. At least 70-80% of the patients with Hodgkin lymphoma (HL) can be cured with first-line therapy with the improvement of staging methods and the introduction of increasingly effective chemotherapy regimens during the last 50 years [[1]]. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF